Karyopharm Therapeutics Inc. announced preliminary unaudited earnings results for the fourth quarter and full year 2020. The company expects total revenues for the fourth quarter of 2020 to be between $35.0 million and $36.0 million. For the year 2020, the company expects total revenues to be between $108.0 million and $109.0 million for the full year of 2020.